Vanguard Wellington U.S. Value Active ETF
VUSV - ETF AI Analysis
Top Page
Vanguard Wellington U.S. Value Active ETF (VUSV)
VUSV, the Vanguard Wellington U.S. Value Active ETF, earns a solid overall rating driven by high-quality leaders like Microsoft and Merck, which combine strong financial performance with attractive long-term growth prospects in areas such as cloud, AI, and healthcare innovation. Additional support comes from financially robust holdings like Chubb and Intercontinental Exchange, though names such as Berkshire Hathaway and James Hardie, with bearish technical trends, cash flow or valuation concerns, modestly weigh on the fund’s appeal. The main risk factor is the ETF’s reliance on a relatively concentrated set of large U.S. companies, meaning weakness in a few key holdings could have an outsized impact.
VUSV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 94.11M
- Region
- North America
- Expense Ratio
- 0.30%
- Beta
- 0.56
- Issuer
- Vanguard
- Inception Date
- Nov 14, 2025
- Dividend Yield
- 0.17%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
VUSV Summary
Vanguard Wellington U.S. Value Active ETF (VUSV) is an actively managed fund that focuses on U.S. companies considered undervalued based on basics like earnings and sales. It doesn’t track a fixed index, but instead follows a value-investing theme across many sectors, including financials, health care, and technology. Well-known holdings include Microsoft and Amazon, along with other large U.S. firms. Investors might consider VUSV for long-term growth and diversification, especially if they believe undervalued companies can outperform over time. A key risk is that value stocks can stay out of favor for long periods, and the ETF’s price can go up and down with the overall market.
How much will it cost me?
The Vanguard Wellington U.S. Value Active ETF (VUSV) has an expense ratio of 0.30%, meaning you’ll pay $3 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?
The Vanguard Wellington U.S. Value Active ETF (VUSV) could benefit from a strong U.S. economy, as its focus on undervalued companies across sectors like financials, healthcare, and technology may lead to growth opportunities. However, rising interest rates or economic slowdowns could negatively impact its financial and industrial holdings, while regulatory changes in healthcare or technology might also pose risks. Its active management approach provides flexibility to adapt to market changes, but it may underperform if value stocks fall out of favor.
VUSV Top 10 Holdings
VUSV leans heavily into U.S. blue chips, with Microsoft and Amazon acting as the tech workhorses—though both have seen mixed to lagging short‑term moves, they still set the tone for the fund’s growth side. The real ballast comes from value‑tilted names like Berkshire Hathaway and Chubb, both rising steadily and helping smooth out volatility. Merck adds a strong health care engine, while Intercontinental Exchange has been climbing and quietly boosting returns. Overall, the ETF is U.S.-focused, with a clear tilt toward financials, health care, and established tech rather than flashy momentum plays.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MSFT | Microsoft | 6.88% | $6.51M | $3.96T | 2.45% | 79Outperform |
 AMZN | Amazon | 5.84% | $5.52M | $2.93T | 6.85% | 71Outperform |
 BRK.B | Berkshire Hathaway B | 3.37% | $3.19M | $1.25T | 18.34% | 66Neutral |
 MRK | Merck & Company | 2.58% | $2.44M | $364.98B | 61.83% | 80Outperform |
 CB | Chubb | 2.29% | $2.17M | $141.03B | 26.64% | 80Outperform |
 ICE | Intercontinental Exchange | 2.03% | $1.92M | $98.56B | 18.82% | 80Outperform |
 MS | Morgan Stanley | 1.89% | $1.79M | $293.16B | 14.48% | 76Outperform |
 EMR | Emerson Electric Company | 1.79% | $1.70M | $91.91B | 28.97% | 76Outperform |
 DIS | Walt Disney | 1.78% | $1.68M | $205.84B | 4.18% | 75Outperform |
 JHX | James Hardie Industries PLC | 1.76% | $1.66M | $16.90B | 66.65% | 66Neutral |
VUSV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VUSV, the sentiment is Positive. The current price of 73.65 is above the 20-day moving average (MA) of 72.11, above the 50-day MA of 70.86, and above the 200-day MA of 67.91, indicating a bullish trend. The MACD of 0.74 indicates Negative momentum. The RSI at 63.11 is Neutral, neither overbought nor oversold. The STOCH value of 79.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VUSV.
VUSV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| VUSV | $73.65 | $78.00(5.90% Upside) | $94.11M | 0.30% | 68Neutral |
 BAMD | $34.31 | $38.05(10.89% Upside) | $98.69M | 0.87% | 71Outperform |
 SASS | $24.69 | $30.07(21.77% Upside) | $78.81M | 0.75% | 64Neutral |
 CVAR | $32.51 | $35.36(8.78% Upside) | $47.78M | 0.87% | 57Neutral |
 GVLE | $49.64 | $56.36(13.54% Upside) | $41.31M | 0.45% | 69Neutral |
 USFE | $37.91 | $43.96(15.95% Upside) | $4.91M | 0.45% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VUSV | Vanguard Wellington U.S. Value Active ETF | 73.65 | 14.26 | 24.01% | |
| BAMD | Brookstone Dividend Stock ETF | 34.31 | 5.15 | 17.65% | |
| SASS | M.D. Sass Concentrated Value ETF | 24.69 | -0.42 | -1.68% | |
| CVAR | Cultivar ETF | 32.51 | 5.17 | 18.92% | |
| GVLE | Goldman Sachs Value Opportunities ETF | 49.64 | 10.54 | 26.96% | |
| USFE | First Eagle US Equity ETF | 37.91 | 3.03 | 8.68% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.